Showing results (31-40 of 100) with videos related to
Sort By:
Pageof 10
Clinical Lung Cancer|June 26, 2022
Characterization of ERBB2 (HER2) Alterations in Metastatic Non-small Cell Lung Cancer and Comparison of Outcomes of Different Trastuzumab-based RegimensSarah Waliany, Heather Wakelee, Kavitha Ramchandran, et al.Plos One|May 24, 2018
Incidence of lung cancer histologic cell-types according to neighborhood factors: A population based study in CaliforniaMindy C DeRouen, Lauren Hu, Meg McKinley, et al.Cancer Epidemiology|April 28, 2015
ALK rearrangement testing and treatment patterns for patients with ALK-positive non-small cell lung cancerAnnie Guérin, Medha Sasane, Jie Zhang, et al.Journal of the National Cancer Institute|November 20, 2024
Elevated risk of lung cancer among Asian American women who have never smoked: an emerging cancer disparityScarlett Lin Gomez, Mindy DeRouen, Moon S Chen, et al.European Journal of Cancer (Oxford, England : 1990)|December 20, 2025
Bridging the gap in lung cancer: A comprehensive global strategy for changeKostas N Syrigos, Mary E Bussell, Humaid O Al-Shamsi, et al.The Journal of Thoracic and Cardiovascular Surgery|September 3, 2017
Survival and risk factors for progression after resection of the dominant tumor in multifocal, lepidic-type pulmonary adenocarcinomaRebecca W Gao, Mark F Berry, Christian A Kunder, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2021
Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLCSarah Waliany, Han Zhu, Heather Wakelee, et al.Clinical Lung Cancer|May 27, 2008
Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?Corey J Langer, Heather Wakelee, Joan Schiller, et al.Oncoimmunology|October 26, 2020
Association of baseline systemic corticosteroid use with overall survival and time to next treatment in patients receiving immune checkpoint inhibitor therapy in real-world US oncology practice for advanced non-small cell lung cancer, melanoma, or urothelial carcinomaAlexandra Drakaki, Preet K Dhillon, Heather Wakelee, et al.Clinical Lung Cancer|May 16, 2018
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung CancerAlexander L Chin, Kiran A Kumar, Haiwei H Guo, et al.Pageof 10